DSS INC (DSS)
US26253C2017 - Common Stock
DSS Stock Earnings: DSS Reported Results for Q4 2023
DSS just reported results for the fourth quarter of 2023.
The $40 Million EV: How Mullen Lost $1 Billion… And Accidentally Produced the World’s Most Expensive Car
Based on its $1 billion in total losses for 2023, Mullen spent nearly $40 million to produce each of its Mullen GO vehicles.
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is...
DSS chairman Chan acquires 672,173 shares in open market; shares jump (NYSE:DSS)
DSS Chairman Heng Fai Ambrose Chan invests in the company, acquiring over 672k shares in an open market transaction, resulting in a premarket surge of...
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company...
DSS director Heng Fai Ambrose purchases about 672K shares (NYSE:DSS)
DSS director purchases 672,173 shares, totaling $98,137, raising ownership to 19.59M securities. One insider trade in the past year on DSS.
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
Option for Fourth Year Brings Potential Revenue to Over $15 Million...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock
DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical
DSS unit Impact BioMedical sets terms for proposed $8M IPO (NYSE:DSS)
Impact BioMedical, a unit of DSS (DSS), has proposed terms for an $8M IPO. (Read more here.)
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
Company intends to cure the deficiency and return to compliance with NYSE American standard...
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) (
DSS Inc. Issues Letter to Shareholders
CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries...
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed Income...
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc....
DSS, Inc.’s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer to Aggressively Develop Mutual Fund Business for Eventual Spinoff
By David Willey, Benzinga